Health ❯ Obesity ❯ Weight Management

Medications

GLP-1 Drugs GLP-1 Receptor Agonists Tirzepatide GLP-1 Agonists Anti-Obesity Drugs GLP-1 Insurance Coverage Semaglutide Benefits Delivery Services GLP-1 RAs Ozempic Weight Loss Medications Zepbound GLP-1 Therapy Orforglipron Oral Treatments Semaglutide Clinical Trials FDA Approval Patient Access Effects of Weight Loss Medications

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

The lead asset SYH2082 is progressing into Phase 1 following the signing.

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

WeightWatchers Taps Amazon Pharmacy for Faster GLP-1 Access and Delivery

Pilot Study Ties GLP-1 Drugs to Slower Alcohol Absorption and Milder Intoxication

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials